Home » Market News » DirectorsTalk Highlights » Avacta Group Plc Turner Pope Investor Evening
Avacta Group Plc

Avacta Group Plc Turner Pope Investor Evening

Avacta Group Plc (LON:AVCT), the developer of Affimer® biotherapeutics and reagents, has today announced that the Group’s Chief Executive, Alastair Smith, will be presenting at an investor evening hosted by Turner Pope Investments on Wednesday, 3 July 2019. The event will be held in London, EC2 and commence at 4pm.

To register your interest, please email info@turnerpope.com or call on 0203 621 4124.

Avacta’s principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.